Stephens Investment Management Group LLC Buys 50,985 Shares of Icon Plc $ICLR

Stephens Investment Management Group LLC raised its stake in shares of Icon Plc (NASDAQ:ICLR – Free Report) by 7.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 771,246 shares of the medical research company’s stock after purchasing an additional 50,985 shares during the quarter. Icon accounts for about 1.4% of Stephens Investment Management Group LLC’s investment portfolio, making the stock its 11th biggest position. Stephens Investment Management Group LLC owned about 1.01% of Icon worth $131,104,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Icon in the third quarter valued at about $38,000. GAMMA Investing LLC increased its stake in Icon by 21.4% during the second quarter. GAMMA Investing LLC now owns 391 shares of the medical research company’s stock valued at $68,000 after acquiring an additional 69 shares during the period. Fifth Third Bancorp increased its stake in Icon by 1,062.0% during the first quarter. Fifth Third Bancorp now owns 918 shares of the medical research company’s stock valued at $102,000 after acquiring an additional 839 shares during the period. Parkside Financial Bank & Trust increased its stake in Icon by 120.0% during the second quarter. Parkside Financial Bank & Trust now owns 616 shares of the medical research company’s stock valued at $107,000 after acquiring an additional 336 shares during the period. Finally, Bessemer Group Inc. raised its holdings in Icon by 804.8% in the 1st quarter. Bessemer Group Inc. now owns 1,312 shares of the medical research company’s stock valued at $145,000 after acquiring an additional 1,167 shares in the last quarter. Institutional investors own 95.61% of the company’s stock.

Insider Transactions at Icon

In other Icon news, CEO Barry Balfe sold 5,175 shares of the stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $206.66, for a total transaction of $1,069,465.50. Following the completion of the transaction, the chief executive officer directly owned 9,291 shares in the company, valued at $1,920,078.06. This represents a 35.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Emer Lyons sold 264 shares of Icon stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $206.66, for a total value of $54,558.24. Following the transaction, the chief accounting officer directly owned 1,217 shares of the company’s stock, valued at approximately $251,505.22. The trade was a 17.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 33,916 shares of company stock valued at $6,514,252. 44.00% of the stock is owned by insiders.

Wall Street Analyst Weigh In

ICLR has been the topic of several recent research reports. Deutsche Bank reissued a “buy” rating and set a $250.00 price objective on shares of Icon in a report on Thursday, October 29th. Weiss Ratings upgraded Icon from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, October 28th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $254.00 target price on shares of Icon in a research report on Thursday, October 29th. Evercore reiterated an “outperform” rating and set a $240.00 price target on shares of Icon in a research note on Wednesday, October 28th. Finally, Bank of America raised shares of Icon from an “underperform” rating to a “neutral” rating and set a $185.00 price target on the stock in a report on Friday, October 9th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Icon currently has a consensus rating of “Moderate Buy” and an average price target of $213.76.

View Our Latest Analysis on ICLR

Icon Trading Up 0.1%

ICLR stock opened at $195.16 on Thursday. Icon Plc has a 1-year low of $66.57 and a 1-year high of $219.04. The firm has a market cap of $14.94 billion, a P/E ratio of 33.59, a P/E/G ratio of 10.80 and a beta of 1.19. The business’s 50 day moving average is $180.99 and its 200-day moving average is $147.57. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.37.

Icon (NASDAQ:ICLR – Get Free Report) last issued its earnings results on Tuesday, October 27th. The medical research company reported $2.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.62 by $0.04. The business had revenue of $2.02 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Icon had a return on equity of 7.73% and a net margin of 5.45%. Icon’s quarterly revenue was down .9% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.31 EPS. Equities analysts anticipate that Icon Plc will post 9.71 earnings per share for the current fiscal year.

Icon Company Profile

(Free Report)

ICON plc is a global contract research organization (CRO) that provides outsourced development services to pharmaceutical, biotechnology, medical device and government organizations. Its work supports the development of medicines and other healthcare products from early research through clinical trials and regulatory submission. The company’s services include clinical trial design and management, data management and biostatistics, regulatory support, laboratory services, medical imaging and patient recruitment.

Further Reading

Want to see what other hedge funds are holding ICLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR – Free Report).

Institutional Ownership by Quarter for Icon (NASDAQ:ICLR)

Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.